Annual Research Ethics Day Conference 2026 — The Future of Research Ethics: Threats & Opportunities

9 a.m. Central Time — Welcome & Land Acknowledgment

Moderator: Susan M. Wolf, JD, Regents Professor; McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Drinker Professor of Law; Professor of Medicine; Chair, Consortium on Law and Values in Health, Environment & the Life Sciences, University of Minnesota

Joanne Billings, MD, MPH, Interim Vice President for Research & Innovation; Associate Professor of Medicine, University of Minnesota

9:15 a.m. Central Time — Research Ethics 2026: Advancing Ethics in a Shifting Landscape

Moderator: Francis X. Shen, JD, PhD, Professor of Law; Solly Robbins Distinguished Research Fellow; Co-Chair, Consortium on Law and Values in Health, Environment & the Life Sciences, University of Minnesota; Chief Innovation Officer, Center for Law, Brain & Behavior, Massachusetts General Hospital

Christine Grady, MSN, PhD, former-Chief of Bioethics and Head, Section on Human Subjects Research, Clinical Center, National Institutes of Health (NIH)

Kirsten Bibbins-Domingo, PhD, MD, MAS, Lee Goldman, MD Endowed Professor of Medicine, Professor of Epidemiology & Biostatistics, University of California San Francisco (UCSF); Editor-in-Chief, Journal of the American Medical Association (JAMA) and JAMA Network

Q&A

10:15 a.m. Central Time — New Challenges in Research Ethics Oversight: Where Do IRBs Go from Here? What Else Is Needed?

Moderator: Melissa A. Geller, MD, MS, Professor, Department of Obstetrics, Gynecology & Women's Health, Division of Gynecologic Oncology; Associate Director of Clinical Research, Masonic Cancer Center, University of Minnesota

Barbara E. Bierer, MD, Director and Principal Investigator, SMART IRB; Faculty Director, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center); Professor of Medicine and Member of the Center for Bioethics, Harvard Medical School

Holly Fernandez Lynch, JD, MBE, Co-Chair, AEREO: The Consortium to Advance Effective Research Ethics Oversight; Associate Professor of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania

Q&A

11:15 a.m. Central Time — Break

15 minute break

11:30 a.m. Central Time — Ensuring Research Integrity in a Changing Environment: What Standards and Oversight Will Advance Trustworthy Science?

Moderator: Kimberly Kirkpatrick, PhD, Associate Vice President for Research, Infrastructure and Interdisciplinary Institutes and Centers, Research Integrity & Compliance, Research & Innovation Office (RIO), University of Minnesota

Arthur Lupia, PhD, Gerald R. Ford Distinguished University Professor; Vice President for Research & Innovation, University of Michigan

Susan Garfinkel, PhD, Consultant, Research Integrity Partners; former-Associate Vice President for Research Compliance, Ohio State University; former-Director, Division of Investigative Oversight, U.S. Office of Research Integrity (ORI)

Q&A

12:30 p.m. Central Time — Lunch Break

30 minute break

1 p.m. Central Time — Advancing Trust and Ethics in Community-Based Research: What Are the Next Steps Needed?

Moderator: Mary J. Owen, MD, Associate Dean of Native American Health; Endowed Professor of Native American Health; Director, Center of American Indian and Minority Health, University of Minnesota Medical School

Vence L. Bonham Jr., JD, Professor; Founding Director, Center for Bioethics, Social, and Behavioral Research; President and CEO, Diaspora Human Genomics Institute, Meharry Medical College

Maya Sabatello, LLB, PhD, Associate Professor of Medical Sciences, Center for Precision Medicine & Genomics and Division of Ethics, Department of Medicine and Department of Medical Humanities & Ethics, Columbia University

Q&A

2 p.m. Central Time — Evolving Research Ethics to Manage Cutting-Edge Technologies: How Should Ethics Evolve to Address Challenges from AI and Xenotransplants to Biowarfare?

Moderator: Robert C. Hampshire, PhD, Executive Director, Research Development Office, Research & Innovation Office (RIO), University of Minnesota

Brendan Parent, JD, Director of Medical Ethics; Director, Transplant Ethics & Policy Group; Associate Professor, Departments of Population Health and Surgery, New York University Grossman School of Medicine

Efthimios Parasidis, JD, MBE, Kara J. Trott Endowed Professor in Law, Moritz College of Law; Professor of Public Health; Faculty Affiliate, Center for Bioethics, Ohio State University

Q&A

2:55 p.m. Central Time — Closing Remarks

Susan M. Wolf, JD, Regents Professor; McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Drinker Professor of Law; Professor of Medicine; Chair, Consortium on Law and Values in Health, Environment & the Life Sciences, University of Minnesota

3:00 p.m. Central Time — Adjourn

End of event

2026 Research Ethics Day Planning Committee

• Joanne Billings, MD, MPH
• Kimberly Kirkpatrick, PhD
• Shashank Priya, PhD
• Danielle Rintala, PhD
• Francis X. Shen, JD, PhD
• Susan M. Wolf, JD

2026 Research Ethics Day Advisory Committee

• Kenneth Beckman, PhD*
• Lynne Borden, PhD
• Erik T. Brown, PhD
• Debra Debruin, PhD*
• Debra Dykhuis, CIP
• Milton Eder, PhD
• Melissa A. Geller, MD, MS*
• Jody Gray, MLIS
• Alonso Guedes, DVM, MS, PhD, DACVAA
• Reynolds-Anthony Harris*
• David Ingbar, MD*
• Victoria Interrante, PhD*
• Alison Joglekar, PhD*
• Patricia Khashayar, MD, PhD, MBA*
• Kimberly Kirkpatrick, PhD
• Joseph A. Konstan, PhD
• Mindy Kurzur, PhD*
• Joel Larson, MPP*
• Danielle Rintala, PhD
• Milena Sawui-Salces, PhD
• Shashi Shekhar, PhD
• Francis X. Shen, JD, PhD*
• Frank Symons, PhD
• Mehmet Toner, PhD*
• Susan M. Wolf, JD*

*indicates Consortium member center representative or Consortium leadership

AERO: The Consortium to Advance Effective Research Oversight. AEREO: Advancing Effective Research Ethics Oversight. Accessed December 10, 2025.

Aguirre, Alejandra, Sandra Soo-Jin Lee, Shawneequa Callier, et al. "Towards Trustworthiness of Precision Medicine Research for People with Disabilities." Nature Genetics 57 (2025): 1321–1324.

Anderson, Anna M., Rachelle A. Martin, Willyanne DeCormier Plosky, et al. "A Global Call to Action for Disability Inclusion in Health Research." Nature Medicine 31 (2025): 1399-1403.

Angus, Derek C., Rohan Khera, Tracy Lieu, et al. "AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence." JAMA 334, no. 18 (2025): 1650-1664.

Beck, Kelly B., Kristen T. MacKenziem, Anne V. Kirby, et al. "Guidelines for the Creation of Accessible Consent Materials and Procedures: Lessons from Research with Autistic People and People with Intellectual Disability." Autism in Adulthood. 2025 Feb 19. Epub ahead of print.

Bibbins-Domingo, Kirsten, Linda Brubaker, and Greg Curfman. "The 2024 Revision to the Declaration of Helsinki: Modern Ethics for Medical Research." JAMA 333, no. 1 (2025): 30-31.

Bibbins-Domingo, Kirsten, Robert O. Bonow, Neil M. Bressler, et al. "Reaffirming the JAMA Network Commitment to the Health of Patients and the Public." JAMA 333, no. 13 (2025): 1121-1122.

Bierer, Barbara E. "Declaration of Helsinki—Revisions for the 21st Century." JAMA 333, no. 1 (2025): 18-19.

Bonham, Vence L., Kiana Amini, Ashley J. Buscetta, et al. "Democratizing Education for Sickle Cell Disease Gene Therapy: A Community-Based Model for Creating Patient Education Materials." Public Health Genomics 28, no 1. (2025): 292-300.

Coleman, Carl H., Alireza Khadem, John C. Reeder, et al. "A World Health Organization Tool for Assessing Research Ethics Oversight Systems." Bulletin of the World Health Organization 103, no. 6 (2025): 403-409.

Emanuel, Ezekiel J., David Wendler, and Christine Grady. "What Makes Clinical Research Ethical?" JAMA 283, no. 20 (2000): 2701-2711.

Floyd, K. Jameson, Faeben Wossenseged, Ashley J. Buscetta, et al. "Views of Adults Living with Sickle Cell Disease on the Theoretical Return of Secondary Genomic Findings." Genetics in Medicine 26, no. 1 (2024): 100993.

Garfinkel, Susan, Sabina Alam, Patricia Baskin, et al. "Enhancing Partnerships of Institutions and Journals to Address Concerns About Research Misconduct: Recommendations From a Working Group of Institutional Research Integrity Officers and Journal Editors and Publishers." JAMA Network Open 6, no. 6 (2023): e2320796.

Horizon Europe. "The Future of Research Ethics Review in the Changing Research Environments." 2025.

Khush, Kiran K., James L. Bernat, Richard N. Pierson III, et al. "Research Opportunities and Ethical Considerations for Heart and Lung Xenotransplantation Research: A Report from the National Heart, Lung, and Blood Institute Workshop." American Journal of Transplantation 24, no. 6 (2024): 918-927.

Kirkpatrick, Kimberly. “Open Science from the Academic Perspective.” Posted at Association of Ecosystem Research Centers (AERC). “2024 Congressional Briefing: Open Science in Ecosystem Research.” September 18, 2024.

Kratsios, Michael J., Director, Office of Science and Technology Policy. "Memorandum for the Heads of Executive Departments and Agencies: Agency Guidance for Implementing Gold Standard Science in the Conduct and Management of Scientific Activities." June 23, 2025.

Kratsios, Michael J. "Sound Policy Demands Sound Science." Science 389, no. 6755 (2025): 7.

Lupia, Arthur, David B. Allison, Kathleen Hall Jamieson, et al. "Trends in US Public Confidence in Science and Opportunities for Progress." PNAS 121, no. 11 (2024): e2319488121.

Lynch, Holly Fernandez, Elisa A. Hurley, Holly A. Taylor. "Responding to the Call to Meaningfully Assess Institutional Review Board Effectiveness." JAMA 330, no. 3 (2023): 221-222.

Lynch, Holly Fernandez, Emily A. Largent, Matthew S. McCoy, et al. "Advancing Trust in Science: Institutional Obligations to Promote Research Integrity." Journal of Law, Medicine & Ethics 53, no. 1 (2025): 1-5.

Lynch, Holly Fernandez, and Holly A. Taylor. "How Do Accredited Organizations Evaluate the Quality and Effectiveness of Their Human Research Protection Programs?" AJOB Empirical Bioethics 14, no. 1 (2023): 23-37.

Lynch, Holly Fernandez, Ivy Tillman, Elyse I. Summers, et al. "Preserving Research Ethics Oversight Amid Decimation of the Research Enterprise." JAMA 333, no. 24 (2025): 2143-2144.

Lynch, Holly Fernandez, and Stephen Rosenfeld. "Institutional Review Board Quality, Private Equity, and Promoting Ethical Human Subjects Research." Annals of Internal Medicine 173, no. 7 (2020): 558-562.

Lynch, Holly Fernandez, Whitney Eriksen, Justin T. Clapp. "'We Measure What We Can Measure': Struggles in Defining and Evaluating Institutional Review Board Quality." Social Science & Medicine 292, no. 114614 (2022).

Madden, Ebony B., Lucia A. Hindorff, Vence L. Bonham, et al. "Advancing Genomics to Improve Health Equity." Nature Genetics 56 (2024): 752-757.

McDonald, Katherine E., Ariel E. Schwartz, Robert Dinerstein, et al. "Responsible Inclusion: A Systematic Review of Consent to Social-Behavioral Research with Adults with Intellectual Disability in the U.S." Disability and Health Journal 17, no. 4 (2024): 101669.

National Academies of Science, Engineering, and Medicine. Assessing Research Security Efforts in Higher Education: Proceedings of a Workshop. National Academies Press, 2025.

National Academies of Science, Engineering, and Medicine. "On Being a Scientist: An Updated and Online Guide to the Responsible and Ethical Conduct of Research." 2025.

National Academies of Science, Engineering, and Medicine. Simplifying Research Regulations and Policies: Optimizing American Science. National Academies Press, 2025.

National Academies of Science, Engineering, and Medicine. "The Strategic Council for Research Excellence, Integrity, and Trust." 2025.

National Academy of Medicine. "Action Collaborative on Translating Emerging Science, Technology, and Innovation in Health and Medicine." Accessed December 10, 2025.

National Research Council and National Academy of Engineering. Emerging and Readily Available Technologies and National Security: A Framework for Addressing Ethical, Legal, and Societal Issues. National Academies Press, 2014.

Nosek, Brian A. "Science Becomes Trustworthy by Constantly Questioning Itself." PLOS Biology 23, no. 8 (2025): e3003334.

Nosek, Brian A., David B. Allison, Kathleen Hall Jamieson, et al. “A Framework for Assessing the Trustworthiness of Scientific Research Findings.” Proceedings of the National Academy of Sciences (in press).

Owen, Mary, and Matthew Tobey. "Addressing Inaccuracies in American Indian and Alaska Native Health Data Is a Work in Progress." JAMA 334, no. 3 (2025): 217-218.

Parasidis, Efthimios. America's Military Biomedical Complex: Law, Ethics, and the Drive for Scientific Innovation. Oxford University Press, 2024.

Parent, Brendan, Olivia S. Kates, Wadih Arap, et al. "Research Involving the Recently Deceased: Ethics Questions that Must Be Answered." Journal of Medical Ethics 50, no. 9 (2024): 622-625.

Reis, Andreas Alois, Ross Upshur, and Keymanthri Moodley. "Future-Proofing Research Ethics – Key Revisions of the Declaration of Helsinki 2024." JAMA 333, no. 1 (2025): 20-21.

Research & Innovation Office, University of Minnesota. Research Development Office. 2025.

Rothstein, Mark A., and Leslie E. Wolf. "National Research Act at 50: An Ethics Landmark in Need of an Update." The Hastings Center for Bioethics. July 12, 2024.

Rubin, Erin J., and Kirsten Bibbins-Domingo. "This System Is Critical to Americans’ Health. We Must Defend It." The Washington Post. July 21, 2025.

Sabatello, Maya, Daphne O. Martschenko, Mildred K. Cho, et al. "Data Sharing and Community-Engaged Research." Science 378, no. 6616 (2022): 141-143.

Sabatello, Maya, and Katherine E. McDonald. "Team Science in Precision Medicine Research: The Case for Inclusion of Adults With Intellectual Disability." American Journal on Intellectual and Developmental Disabilities 130, no. 3 (2025): 171-177.

Seykora, Andrea, Carl Coleman, Stephen J. Rosenfeld, et al. "Steps toward a System of IRB Precedent: Piloting Approaches to Summarizing IRB Decisions for Future Use." Ethics & Human Research 43, no. 6 (2021): 2-18.

SmartIRB. "SmartIRB: Supporting Single IRB Review and Advancing Collaborative Research." 2025.

Thorp, H. Holden. "Gold Standard Science Requires Gold Standard Scholarship." Science 389, no. 6766 (2025): 1165.

The White House. "Executive Order 14303: Restoring Gold Standard Science." May 23, 2025.

It is the policy of the University of Minnesota to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. All participating faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance to manage and resolve any possible conflicts of interest. Specific disclosure information for each faculty member will be shared with the audience prior to the faculty’s presentation.

Speaker and moderator disclosures are forthcoming.

Accreditation Statement 

In support of improving patient care, University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Minnesota Board of Continuing Legal Education
An application will be submitted to the Minnesota Board of Continuing Legal Education. Determination of credit eligibility is pending review.

CIP® Council
An application will be submitted to the CIP® Council. Determination of credit eligibility is pending review.

Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Note: You must participate in the live webinar to be eligible to claim credit. Credit will not be made available for viewing the recording.

Kirsten Bibbins-Domingo, PhD, MD, MAS, is Lee Goldman, MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics at the University of California San Francisco (UCSF). She is Editor-in-Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network. Dr. Bibbins-Domingo is a general internist, cardiovascular disease epidemiologist, and a national leader in prevention and interventions to address health disparities. As an NIH-funded researcher, she has used observational studies, pragmatic trials, and simulation modeling to examine effective interventions aimed at prevention. She co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital that generates actionable research to increase health equity and reduce health disparities in at-risk populations. Dr. Bibbins-Domingo was a member of the U.S. Preventive Services Task Force from 2010-17, leading the Task Force as the Vice-Chair and Chair from 2014-17. She is an inducted member of the American Society for Clinical Investigation, Association of American Physicians, National Academy of Medicine, and American Academy of Arts and Sciences.

Barbara E. Bierer, MD, is the Faculty Director of the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center); Professor of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston; and a hematologist/oncologist. She is the Director of SMART IRB and Director of the Regulatory Foundations, Ethics and Law Program of the Harvard Clinical and Translational Science Center. Dr. Bierer is also a faculty member in the Center for Bioethics at Harvard Medical School, and Affiliate Faculty in the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. She previously served as Chair of the Secretary’s Advisory Committee for Human Research Protections (SACHRP), U.S. Department of Health and Human Services; as a member of the National Academies of Sciences Committee on Science, Technology and the Law; and on the Boards of Directors of the Association for Accreditation of Human Research Protection Programs (AAHRPP) and Public Responsibility in Medicine and Research (PRIM&R).

Joanne Billings, MD, MPH, serves as the University of Minnesota’s Interim Vice President for Research and Innovation, overseeing a $1+ billion research enterprise across all campuses and facilities. In this role, she manages units responsible for the administration of sponsored projects, research and regulatory compliance, technology commercialization, and corporate engagement, as well as 14 interdisciplinary academic centers and institutes. Dr. Billings also continues to serve as Associate Vice President for Research Integrity and Compliance. She is an Associate Professor of Medicine in the University of Minnesota Medical School. As a pulmonologist and critical care physician, she focuses on the care of people with cystic fibrosis (CF).

Vence L. Bonham Jr., JD, is the newly appointed President and Chief Executive Officer of the Diaspora Human Genomics Institute (DHGI) and Founding Director of the Meharry Center for Bioethics, Social and Behavioral Research (MCBSBR) at Meharry Medical College. In 2023, DHGI launched an international 10-year research project to build the first comprehensive database for people of African ancestry to address the underrepresentation of Black populations in genomic and medical research. MCBSBR advances interdisciplinary scholarship at the intersection of ethics, genomics, and health, examining how social, cultural, and behavioral factors shape health outcomes. Previously, Prof. Bonham served as Acting Director and Deputy Director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH).

Holly Fernandez Lynch, JD, MBE, is Associate Professor of Medical Ethics in the Department of Medical Ethics and Health Policy at the Perelman School of Medicine (PSOM), University of Pennsylvania. She co-chairs the PSOM Research Ethics and Policy Series and serves as Associate Faculty Director of Online Educational Initiatives in the department, where she helps lead the Masters of Health Care Innovation. She has a secondary appointment as Associate Professor of Law at the University of Pennsylvania Carey Law School. Prof. Fernandez Lynch is founder and co-chair of the Consortium to Advance Effective Research Ethics Oversight (AEREO), a collaborative effort established in 2018 to understand, evaluate, and improve IRB quality and effectiveness. She served as a member of the U.S. Department of Health and Human Services Secretary’s Advisory Committee on Human Research Protections (SACHRP) from 2014-19. She is currently Board President of the American Society for Law, Medicine & Ethics (ASMLE).

Susan Garfinkel, PhD, is the owner of Research Integrity Partners, supporting institutions and Research Integrity Officers in managing research integrity issues, and assisting editors and publishers with publication ethics. Formerly, she was the Associate Vice President for Research Compliance at The Ohio State University, where she managed research misconduct matters and fostered ethical research practices. She was the Director for the Division of Investigative Oversight in the U.S. Office of Research Integrity (ORI) responsible for the oversight of research misconduct matters nationally and internationally. She also was Director of Research Grants for a nonprofit organization and Program Officer at the National Heart, Lung and Blood Institute (NHLBI), at the National Institutes of Health (NIH). She serves on the Board of Trustees for the Committee on Publication Ethics (COPE).

Melissa A. Geller, MD, MS, is Professor in the Department of Obstetrics, Gynecology & Women's Health, Division of Gynecologic Oncology; Associate Director of Clinical Research for the Masonic Cancer Center; and Director of Research for the Division of Gynecologic Oncology at the University of Minnesota. In addition, she serves on the NRG Oncology Developmental Therapeutics/Phase I/Experimental Medicine Committee. She specializes in the treatment and management of gynecologic malignancies through clinical and translational research. Dr. Geller is currently the primary investigator on multiple clinical trials involving the use of natural killer (NK) cell immunotherapy for women with recurrent ovarian cancer. She is also funded through a U.S. Department of Defense award to create and test an interactive mobile phone application aimed to educate ovarian cancer patients about genetic counseling and testing.

Christine Grady, MSN, PhD, is former-Chief of Bioethics and Head of the Section on Human Subjects Research in the Clinical Center at the National Institutes of Health (NIH). She is a nurse-bioethicist and a senior investigator who has published widely in the biomedical and bioethics literature and co-authored or edited several books, including The Oxford Textbook of Clinical Research Ethics. Her conceptual and empirical contributions have focused on the ethics of clinical research and the ethical issues confronting nurses and other health care professionals. She served from 2010-17 as a member of the President's Commission for the Study of Bioethical Issues.  She is an elected fellow of The Hastings Center and of the American Academy of Nursing, a senior research fellow at the Kennedy Institute of Ethics, and an elected member of the National Academy of Medicine. She has received multiple awards including a Lifetime Achievement Award from the American Society for Bioethics & the Humanities (ASBH).

Robert C. Hampshire, PhD, is Executive Director of the Research Development Office in the Research & Innovation Office at the University of Minnesota. In this role, he is building an office to support large-scale interdisciplinary initiatives and secure funding. Previously, Dr. Hampshire was Associate Research Professor at the University of Michigan's Michigan Institute for Data Science, and was Chief Science Officer and Acting Assistant Secretary in the Office of Research and Technology at the U.S. Department of Transportation. He has advised the White House, the Department of Defense, the Department of Energy, the Federal Communications Commission, and Congress; led a $2 billion federal research and technology portfolio; and forged coalitions across academia, industry, and community partners.

Kimberly Kirkpatrick, PhD, is Associate Vice President for Research Capacity Building in the Research & Innovation Office at the University of Minnesota. In this role, she provides leadership in the development, enhancement, management, and review of academic centers and institutes; supervises research infrastructure and resources including the Research Animal Resources facilities and Biosafety Level 3 Program; and oversees University shared research resources, core research services, and related infrastructure. Previously, Dr. Kirkpatrick was a Distinguished Professor of Psychological Sciences and Director of the Cognitive and Neurobiological Approaches to Plasticity Center at Kansas State University. She has served as principal investigator on over $30 million in extramural grants from the National Institutes of Health (NIH) and other agencies.

Arthur Lupia, PhD, is the Gerald R. Ford Distinguished University Professor and Vice President for Research and Innovation at the University of Michigan, where he is responsible for fostering the excellence and integrity of research across all three campuses. He is also Executive Director of Bold Challenges, where he leads collaborations with research centers and institutes across the university to address societal challenges that intersect with equity, health, infrastructure, and sustainability. Dr. Lupia served from 2018-22 as an Assistant Director of the National Science Foundation (NSF), where he developed strategies to increase the public value of research across NSF’s entire portfolio. He also co-chaired the government-wide Subcommittee on Open Science for the White House’s Office of Science and Technology Policy (OSTP) between 2019-22, convening leaders from more than 30 federal agencies to increase access to, and the public value of, federally funded research. Dr. Lupia is a member of the National Academies of Sciences, Engineering, and Medicine’s Strategic Council for Research Excellence, Integrity, and Trust, and serves on the National Academies’ Advisory Board for Engineering and the Physical Sciences.

Mary J. Owen, MD, is Associate Dean of Native American Health; Endowed Professor of Native American Health; and Director of the Center of American Indian and Minority Health at the University of Minnesota Medical School. Her work includes developing regional and national programs to increase the numbers of American Indian and Alaska Native (AIAN) students entering medical careers, outreaching to local and national Native leaders to ensure that the University of Minnesota Medical School remains in tune with AIAN healthcare and education needs, teaching medical students and health care providers important components of providing healthcare to AIAN communities, and developing research efforts to address AIAN health disparities. She continues to provide clinical care at the Center of American Indian Resources in Duluth and is the immediate Past-President of the Association of American Indian Physicians. Dr. Owen is a member of the Auk Kwaan Tribe of the Tlingit people.

Efthimios Parasidis, JD, MBE, holds the Kara J. Trott Endowed Professorship in Law, maintains a joint appointment with the College of Public Health, and is a faculty affiliate with the College of Medicine’s Center for Bioethics at The Ohio State University. He is co-author of a leading graduate-level course book on the ethics and regulation of research with human subjects, and author of America’s Military Biomedical Complex: Law, Ethics, and the Drive for Scientific Innovation (Oxford University Press, 2025). Prof. Parasidis is an appointed member of the National Institutes of Health (NIH) research ethics committee that examines complex and emerging issues in clinical data science. He also serves as an Ethical, Legal, and Societal Issues Team Member on DARPA’s Measuring Biological Aptitude program, and served as a law and bioethics consultant to the U.S. Air Force.

Brendan Parent, JD, is Director of Medical Ethics, Director of the Transplant Ethics & Policy Group, and Associate Professor in the Department of Population Health and the Department of Surgery at New York University Grossman School of Medicine. His research focuses on organ donation, procurement, and transplantation ethics and policy. In addition, Prof. Parent examines ethical issues in genetic technologies, including how to balance privacy, rights to health information, and value of genomic datasets for research enterprises. He also considers how human psychology should inform decisions regarding human genetic engineering. His more recent research includes ethics and policy in gender affirmation care and regulation of big data and artificial intelligence in health care settings.

Maya Sabatello, LLB, PhD, is Associate Professor of Medical Sciences, Center for Precision Medicine & Genomics and Division of Ethics, Department of Medicine and Department of Medical Humanities & Ethics, Columbia University, where she also co-directs the Precision Medicine: Ethics, Politics, and Culture Project. She has extensive experience in national and international policymaking relating to human and disability rights. Dr. Sabatello explores the ethical, social, and policy issues relating to biomedical technologies, genomic information and Big Data and the impacts on social structures, marginalized communities, individual rights, and health outcomes. She serves as a member of the American Society of Human Genetics (ASHG) Professional Practice & Social Implications Committee and the Institutional Review Board (IRB) of NIH’s All of Us Research Program. She was Co-Chair of the Ethics Committee of the International Society of Psychiatric Genetics, and co-chairs the National Human Genome Research Institute (NHGRI) Community Engagement in Genomics Working Group.

Francis X. Shen, JD, PhD, is Professor of Law and Solly Robins Distinguished Research Fellow in the Law School, a faculty member in the Graduate Program in Neuroscience, and Co-Chair of the Consortium on Law and Values at the University of Minnesota. He directs the Shen Neurolaw Lab, whose motto is "Every story is a brain story." In addition, he serves as Chief Innovation Officer of the Center for Law, Brain & Behavior at Massachusetts General Hospital. Prof. Shen is the Founding Director of the Dana Foundation Career Network on Neuroscience & Society. He conducts empirical, legal, and ethical research to examine how insights from neuroscience and artificial intelligence can make the legal system more just and effective. He also explores the ethical, legal, and social implications of advances in neurotechnology.

Susan M. Wolf, JD, is Regents Professor; McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Drinker Professor of Law; Professor of Medicine; and Chair of the Consortium on Law and Values at the University of Minnesota. Her research focuses on the relationship of law, ethics, and biomedicine and on research ethics and integrity. Prof. Wolf is an elected member of the National Academy of Medicine and the American Law Institute, and a fellow of the American Association for the Advancement of Science (AAAS) and The Hastings Center as well as a past-member of the Fellows' Council. She has received numerous grants to support her research, including from the National Institutes of Health (NIH), National Science Foundation (NSF), and The Greenwall Foundation. Prof. Wolf has served on a variety of governmental and institutional panels, and currently serves on the National Academies of Sciences, Engineering, and Medicine’s Strategic Council for Research Excellence, Integrity, and Trust.